These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17516292

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 5. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H.
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [Abstract] [Full Text] [Related]

  • 6. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
    Nezi M, Christopoulos P, Paltoglou G, Gryparis A, Bakoulas V, Deligeoroglou E, Creatsas G, Mastorakos G.
    J Pediatr Endocrinol Metab; 2016 Jun 01; 29(6):693-702. PubMed ID: 27089404
    [Abstract] [Full Text] [Related]

  • 7. [Causes of menstrual disorders in adolescent girls--a retrospective study].
    Bieniasz J, Zak T, Laskowska-Zietek A, Noczyńska A.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Jun 01; 12(3):205-10. PubMed ID: 17020657
    [Abstract] [Full Text] [Related]

  • 8. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
    Singh KB, Mahajan DK, Wortsman J.
    J Reprod Med; 1994 Oct 01; 39(10):805-8. PubMed ID: 7837128
    [Abstract] [Full Text] [Related]

  • 9. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2009 Apr 01; 14(2):153-9. PubMed ID: 19340711
    [Abstract] [Full Text] [Related]

  • 10. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
    Wiksten-Almströmer M, Hirschberg AL, Hagenfeldt K.
    Acta Obstet Gynecol Scand; 2008 Apr 01; 87(11):1162-8. PubMed ID: 18956264
    [Abstract] [Full Text] [Related]

  • 11. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul 01; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 12. Should androgen levels be measured in hirsute women with normal menstrual cycles?
    Mehta A, Matwijiw I, Taylor PJ, Salamon EA, Kredentser JV, Faiman C.
    Int J Fertil; 1992 Jul 01; 37(6):354-7. PubMed ID: 1360456
    [Abstract] [Full Text] [Related]

  • 13. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep 01; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 14. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Sep 01; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

  • 15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 01; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 16. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B, Ozkan S, Bodur H.
    J Obstet Gynaecol Res; 2007 Apr 01; 33(2):166-73. PubMed ID: 17441890
    [Abstract] [Full Text] [Related]

  • 17. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
    Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E.
    Eur J Intern Med; 2008 Oct 01; 19(6):406-12. PubMed ID: 18848173
    [Abstract] [Full Text] [Related]

  • 18. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug 01; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 19. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J, Chanukvadze D.
    Georgian Med News; 2011 Nov 01; 11(200):30-5. PubMed ID: 22201077
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.